Skip to content

Clinical correlation research of Krebs von den Lungen-6 (KL-6) and perioperative pulmonary function in adults receiving continuing low-volume ventilation during valve surgery

Clinical correlation research of Krebs von den Lungen-6 (KL-6) and perioperative pulmonary function in adults receiving continuing low-volume ventilation during valve surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017334
Enrollment
Unknown
Registered
2018-07-25
Start date
2018-01-01
Completion date
Unknown
Last updated
2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute lung injury

Interventions

Control group:no mechanical ventilation during CPB
Experimental group:Continuing low-volum ventilation during CPB

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Patients who received cardiac valve replacement; (2) Valve disease without other cardiac malformations or macrovascular lesions; (3) Age>18 years; (4) sinus rhythm

Exclusion criteria

Exclusion criteria: (1) Reoperation; (2) Preoperative mechanical ventilation' (3) Acute arotic dissection with valve diseases; (4) Preoperative liver dysfunction or chronic kidney diseases; (5) Quit smoking time shorter than three months; (6) Preoperative severe thoracic deformity; (7) Preoperative other cardic diseases, immune system diseases or musculoskeletal diseases; (8) History of tumor diseases; (9) History of allergic to anaesthetic; (10) History of malignant hyperthermia; (11) History of alcohol or sedative dependence; (12) Preoperative Coagulation disorders; (13) Preoperative infective endocarditis; (14) Congenital heart diseases; (15) Coronary artery diseases; (16) Myasthenia gravis; (17) Thrombocytopenia; (18) Preoperative pulmonary dysfunction or COPD; (19) PaO245mmHg; (20) Unwilling to join in this research; (21) Have been included in other programmes.

Design outcomes

Primary

MeasureTime frame
Interleukin-6;Interleukin-8;Interleukin-10;Krebs von den lungen-6;PaO2/FiO2;PA-aO2;

Countries

China

Contacts

Public ContactJia Hu

West China Hospital, Sichuan University

humanjia@qq.com+86 18682560211

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026